Upload
Featured Recent Articles Topics Login Upload

Search Results for 'major aspirin'

major aspirin published presentations and documents on DocSlides.

ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
by mitsue-stanley
ASCEND Randomized placebo-controlled trial of as...
Aspirin for Preventing the Recurrence of Venous
Aspirin for Preventing the Recurrence of Venous
by liane-varnes
Thromboembolism. N . Engl. J Med. 2012;366:1959-...
Rivaroxaban in stable peripheral or carotid artery disease
Rivaroxaban in stable peripheral or carotid artery disease
by basidell
Sonia Anand, on . behalf of the COMPASS Steering C...
Abbreviations: AF: atrial fibrillation, ACS: acute coronary syndrome, BD: twice daily, CAD: corona
Abbreviations: AF: atrial fibrillation, ACS: acute coronary syndrome, BD: twice daily, CAD: corona
by holly
CrCl. : creatinine clearance, CTO: chronic total o...
An open-label, factorial, r
An open-label, factorial, r
by eddey
andomized trial. Monday August 29, 2022. NCT043244...
ANTIPLATELETES AGENTS BY :DR. ISRAA OMAR
ANTIPLATELETES AGENTS BY :DR. ISRAA OMAR
by lam
Platelets play a critical role in thromboembolic d...
Apixaban vs VKA and
Apixaban vs VKA and
by cheryl-pisano
Apixaban vs VKA and Aspirin vs Placebo in Patie...
Perioperative
Perioperative
by pasty-toler
Aspirin & . POISE-2. Neal Gerstein, MD FASE. ...
COMPASS: Show Us the Way for Medical Management of PAD
COMPASS: Show Us the Way for Medical Management of PAD
by miller
Clinical Associate Professor of Medicine. SSM Heal...
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet trea
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet trea
by ThoughtfulTiger
Presenter: . Meng-Jiun. . Chiou. 5Sep2017. 1. Int...
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
Expert Discussion on Antiplatelet for ACS Patients: Controversies for Asian Patients
by GratefulHeart
Akhtar . Fajar. . Muzakkir. New ESC NSTEMI Guidel...
A New Era for NOACs: Program Goals
A New Era for NOACs: Program Goals
by danika-pritchard
Evidence For NOACs in Patients With NVAF-PCI. PIO...
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
New Oral Anticoagulants: A Review
New Oral Anticoagulants: A Review
by phoebe-click
Babak Moini, MD. Veterans Affairs Hospital. Noon ...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by giovanna-bartolotta
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by ellena-manuel
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...